The early preclinical and clinical development of cipargamin (KAE609), a novel antimalarial compound
{{output}}
Background: Cipargamin (KAE609) is a novel spiroindolone class drug for the treatment of malaria, currently undergoing phase 2 clinical development. This review provides an overview and interpretation of the pre-clinical and clin... ...
